Haleon

Haleon

Personal Care Products
Haleon is one of the largest consumer health companies in the world. Formed by a combination of consumer health divisions of GSK, Pfizer, and Novartis, Haleon separated from GSK and went public in July 2022. The firm generates 60% of sales from global power brands including Sensodyne, Advil, Centrum, and Poligrip, that play in many geographies and are often leaders in their respective categories. It also has a number of local brands, including Emergen-C, Eno, Tums, and Caltrate, that are more tailored to regional needs and have strong local brand equity. Overall, Haleon’s brands tackle a variety of silos within consumer health including oral care, digestive health, pain relief, and nutrition.

$40.6B

Market Cap • 9/10/2026

2021

(5 years)

Founded

2022

(4 years ago)

IPO

NYSE

Listing Exchange

Flag of United Kingdom

United Kingdom

Country

Valuation

P/B

1,9

P/S

2,8

P/EBITDA

11,2

P/OCF

11,5

P/FCF

13,2

P/E

19,1

BVPS

4,9

EPS

0,5

Market Cap

Market Cap

40,6B

EV

50,5B

EV/Revenue

3,4

EV/EBITDA

14

EV/EBIT

16

Payout

Dividend Per Share

0,2

Dividend Yield

2%

Buyback Yield

2,4%

Total Yield

4,4%

Dividend Yield 5Y

1,7%

Payout

38,7%

Retained Earnings

36,7B

Profitability

Gross Margin

65%

EBITDA Margin

24,5%

EBIT Margin

21,3%

Net Margin

14,7%

D&A/EBITDA

0%

R&D/Revenue

2,8%

Capex/Revenue

3%

Capex/D&A

96,1%

Capex/OCF

12,7%

SBC/OCF

3,6%

% PPE

6,3%

% Goodwill

0%

ROE

9,9%

ROIC

6%

Leverage

N.D./EBITDA

2,7

Debt/Equity

0%

Current Ratio

0,7

Quick Ratio

0,5

Interest Coverage

751,8%

Premium

Unlock 100% of the data and have immediate access on more than 6.000 companies with updated information!
  • Unrestricted access
  • Unlimited data history
  • Analysis videos
  • Quarterly highlights
  • Customizable financials table
  • Ranking
  • Discussions

...and much more!

Get Premium